{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:52:04Z","timestamp":1791435124715,"version":"4.3.3"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["5336-00022B"],"award-info":[{"award-number":["5336-00022B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Danish Agency for Digitisation Investment Fund for New Technologies","award":["2020-6720"],"award-info":[{"award-number":["2020-6720"]}]},{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","award":["R283-A16461"],"award-info":[{"award-number":["R283-A16461"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R358-2020-2341"],"award-info":[{"award-number":["R358-2020-2341"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R344-2020-1073"],"award-info":[{"award-number":["R344-2020-1073"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["7016-00048B"],"award-info":[{"award-number":["7016-00048B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["2096-00055A"],"award-info":[{"award-number":["2096-00055A"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Novo Nordisk Foundation via the Danish Diabetes Academy","award":["NNF17SA0031406"],"award-info":[{"award-number":["NNF17SA0031406"]}],"id":[{"id":"https:\/\/ror.org\/05xbkrn90","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R484-2024-1666"],"award-info":[{"award-number":["R484-2024-1666"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R358-2020-2342"],"award-info":[{"award-number":["R358-2020-2342"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Hypothesis<\/jats:title>\n                    <jats:p>Individuals with schizophrenia are at increased risk of type 2 diabetes and diabetes-related complications. Whether the detection of hyperglycemia in individuals with schizophrenia is followed by timely clinical action remains insufficiently understood. We hypothesized that glucose-lowering drug (GLD) treatment would be initiated later in individuals with schizophrenia with elevated glycated hemoglobin (HbA1c) than in matched individuals without schizophrenia, and that this delay would be reflected in worse HbA1c trajectories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design<\/jats:title>\n                    <jats:p>We identified all individuals with schizophrenia aged \u226530\u00a0years at the time of the first elevated HbA1c (\u226548\u00a0mmol\/mol) in nationwide Danish registers. These individuals were matched on age, sex, year of elevated HbA1c, and baseline HbA1c with up to five individuals without schizophrenia. In the year following the detection of elevated HbA1c, we compared time to GLD treatment between individuals with and without schizophrenia using a Cox proportional hazard model. Mean HbA1c levels over time were illustrated graphically and compared using linear mixed-effects models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Results<\/jats:title>\n                    <jats:p>We identified 1527 individuals with schizophrenia and 7492 matched comparison individuals. In the year following detection of elevated HbA1c, schizophrenia was associated with a slower rate of GLD treatment initiation (hazard rate ratio [HRR]\u2009=\u20090.88, 95% confidence interval [CI]: 0.81\u20130.94). Consistently, HbA1c decreased more slowly among individuals with schizophrenia. Notably, schizophrenia was associated with a slower rate of GLD treatment initiation among males (HRR\u2009=\u20090.82, 95%CI: 0.74\u20130.90) but not females (HRR\u2009=\u20090.99, 95%CI: 0.87\u20131.11).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Schizophrenia was associated with a slower rate of GLD treatment initiation and slower reductions in HbA1c following detection of elevated HbA1c, particularly among males.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/schbul\/sbag147","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:54:40Z","timestamp":1783598080000},"source":"Crossref","is-referenced-by-count":0,"title":["Delayed Diabetes Treatment and Persistent Hyperglycemia among Individuals with Schizophrenia: a Nationwide Register-Based Study"],"prefix":"10.1093","volume":"52","author":[{"given":"Christopher","family":"Rohde","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University , Aarhus, 8000 ,","place":["Denmark"]},{"name":"Department of Affective Disorders, Aarhus University Hospital\u2014Psychiatry , Aarhus, 8200 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"S\u00f8eby","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University , Aarhus, 8000 ,","place":["Denmark"]},{"name":"Department of Affective Disorders, Aarhus University Hospital\u2014Psychiatry , Aarhus, 8200 ,","place":["Denmark"]},{"name":"Regional Psychiatry Regional Hospital G\u00f8dstrup , 7400 ,","place":["Denmark"]},{"name":"Department of Internal Medicine, Regional Hospital G\u00f8dstrup , 7400 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6221-9601","authenticated-orcid":false,"given":"Pernille","family":"K\u00f8lb\u00e6k","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University , Aarhus, 8000 ,","place":["Denmark"]},{"name":"Department of Affective Disorders, Aarhus University Hospital\u2014Psychiatry , Aarhus, 8200 ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8032-6208","authenticated-orcid":false,"given":"S\u00f8ren Dinesen","family":"\u00d8stergaard","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University , Aarhus, 8000 ,","place":["Denmark"]},{"name":"Department of Affective Disorders, Aarhus University Hospital\u2014Psychiatry , Aarhus, 8200 ,","place":["Denmark"]},{"name":"The Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University , 3217 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"2026100800433808000_ref1","doi-asserted-by":"publisher","first-page":"1395771","DOI":"10.3389\/fendo.2024.1395771","article-title":"Schizophrenia and type 2 diabetes risk: a systematic review and meta-analysis","volume":"15","author":"Dong","year":"2024","journal-title":"Front Endocrinol"},{"key":"2026100800433808000_ref2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00125-021-05609-x","article-title":"Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews","volume":"65","author":"Lindekilde","year":"2021","journal-title":"Diabetologia."},{"key":"2026100800433808000_ref3","doi-asserted-by":"publisher","first-page":"e3504","DOI":"10.1210\/clinem\/dgac204","article-title":"Severe mental illness and the risk of diabetes complications: a Nationwide, register-based cohort study","volume":"107","author":"Scheuer","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026100800433808000_ref4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/s2215-0366(25)00332-3","article-title":"Disparities in diabetes treatment and monitoring for people with and without mental disorders: a systematic review and meta-analysis","volume":"13","author":"Wagner","year":"2026","journal-title":"Lancet Psychiatry"},{"key":"2026100800433808000_ref5","doi-asserted-by":"publisher","DOI":"10.1111\/acps.70114","article-title":"Clinical intervention following detection of incident diabetes within a large psychiatric service system: a chart review study","author":"K\u00f8lb\u00e6k","year":"2026","journal-title":"Acta Psychiatr Scand"},{"key":"2026100800433808000_ref6","doi-asserted-by":"publisher","first-page":"e0287017","DOI":"10.1371\/journal.pone.0287017","article-title":"Diabetes treatment for persons with severe mental illness: a registry-based cohort study to explore medication treatment differences for persons with type 2 diabetes with and without severe mental illness","volume":"18","author":"Bakkedal","year":"2023","journal-title":"PLoS One"},{"key":"2026100800433808000_ref7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/1403494810390728","article-title":"Register-based studies of mental disorders","volume":"39","author":"Munk-J\u00f8rgensen","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026100800433808000_ref8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish civil registration system","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026100800433808000_ref9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish National Patient Register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026100800433808000_ref10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish national prescription registry","volume":"39","author":"Wallach Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026100800433808000_ref11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/clep.S245060","article-title":"Existing data sources in clinical epidemiology: laboratory information system databases in Denmark","volume":"Volume 12","author":"Arendt","year":"2020","journal-title":"Clinical epidemiology"},{"key":"2026100800433808000_ref12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1403494811399956","article-title":"Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving","volume":"39","author":"Thygesen","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026100800433808000_ref13","doi-asserted-by":"publisher","first-page":"110829","DOI":"10.1016\/j.diabres.2023.110829","article-title":"HbA1c-defined prediabetes and progression to type 2 diabetes in Denmark: a population-based study based on routine clinical care laboratory data","volume":"203","author":"Nicolaisen","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"2026100800433808000_ref14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.diabres.2011.06.025","article-title":"Glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus--practical implications","volume":"93","author":"Colagiuri","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"2026100800433808000_ref15","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"2026100800433808000_ref16","author":"Medicin DSfA"},{"key":"2026100800433808000_ref17","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.2337\/dc21-1062","article-title":"Prediabetes defined by first measured HbA(1c) predicts higher cardiovascular risk compared with HbA(1c) in the diabetes range: a cohort study of Nationwide registries","volume":"44","author":"Yahyavi","year":"2021","journal-title":"Diabetes Care"},{"key":"2026100800433808000_ref18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00125-020-05303-4","article-title":"The impact of hospital-diagnosed depression or use of antidepressants on treatment initiation, adherence and HbA(1c)\/LDL target achievement in newly diagnosed type 2 diabetes","volume":"64","author":"Rohde","year":"2020","journal-title":"Diabetologia."},{"key":"2026100800433808000_ref19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/schbul\/sbx043","article-title":"Effectiveness of prescription-based CNS stimulants on hospitalization in patients with schizophrenia: a nation-wide register study","volume":"44","author":"Rohde","year":"2018","journal-title":"Schizophr Bull"},{"key":"2026100800433808000_ref20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/s2215-0366(24)00223-2","article-title":"Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders during the COVID-19 pandemic: a Danish nationwide registry study","volume":"11","author":"Nersesjan","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"2026100800433808000_ref21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.schres.2022.06.034","article-title":"Psychopharmacological treatment patterns prior to a schizophrenia diagnosis: a Danish nationwide study","volume":"246","author":"Rohde","year":"2022","journal-title":"Schizophr Res"},{"key":"2026100800433808000_ref22","first-page":"A4578","article-title":"The validity of the schizophrenia diagnosis in the Danish psychiatric central research register is good","volume":"60","author":"Uggerby","year":"2013","journal-title":"Danish medical journal"},{"key":"2026100800433808000_ref23","doi-asserted-by":"publisher","first-page":"100565","DOI":"10.1016\/j.lanepe.2022.100565","article-title":"Indicators of quality of diabetes care in persons with type 2 diabetes with and without severe mental illness: a Danish nationwide register-based cohort study","volume":"26","author":"Knudsen","year":"2023","journal-title":"The Lancet Regional Health \u2013 Europe"},{"key":"2026100800433808000_ref24","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1192\/bjp.2020.248","article-title":"Risk of mortality and complications in patients with schizophrenia and diabetes mellitus: population-based cohort study","volume":"219","author":"Chan","year":"2021","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"2026100800433808000_ref25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.euroneuro.2024.11.002","article-title":"Risk of mortality and complications in patients with severe mental illness and co-occurring diabetes mellitus: a systematic review and meta-analysis","volume":"91","author":"Ho","year":"2025","journal-title":"Eur Neuropsychopharmacol"},{"key":"2026100800433808000_ref26","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13101087","article-title":"Gender-related factors in medication adherence for metabolic and cardiovascular health","volume":"13","author":"Venditti","year":"2023","journal-title":"Metabolites."},{"key":"2026100800433808000_ref27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051981","article-title":"Adherence to Oral antidiabetic drugs in patients with type 2 diabetes","volume":"12","author":"Piragine","year":"2023","journal-title":"Systematic Review and Meta-Analysis Journal of clinical medicine"},{"key":"2026100800433808000_ref28","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s00125-023-05891-x","article-title":"Sex differences in type 2 diabetes","volume":"66","author":"Kautzky-Willer","year":"2023","journal-title":"Diabetologia."},{"key":"2026100800433808000_ref29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1176\/appi.ps.201600460","article-title":"Quality and predictors of diabetes care among patients with schizophrenia: a Danish Nationwide study","volume":"69","author":"J\u00f8rgensen","year":"2018","journal-title":"Psychiatr Serv (Wash DC)"},{"key":"2026100800433808000_ref30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.psychres.2017.01.049","article-title":"Are people with schizophrenia adherent to diabetes medication?","volume":"250","author":"Gorczynski","year":"2017","journal-title":"A comparative meta-analysis Psychiatry research"},{"key":"2026100800433808000_ref31","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/wps.20458","article-title":"Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis","volume":"16","author":"Vancampfort","year":"2017","journal-title":"World psychiatry: official journal of the World Psychiatric Association (WPA)"},{"key":"2026100800433808000_ref32","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/wps.20252","article-title":"Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis","volume":"14","author":"Vancampfort","year":"2015","journal-title":"World psychiatry: official journal of the World Psychiatric Association (WPA)"},{"key":"2026100800433808000_ref33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1192\/bjp.2019.20","article-title":"Dietary intake of people with severe mental illness: systematic review and meta-analysis","volume":"214","author":"Teasdale","year":"2019","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"2026100800433808000_ref34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr Bull"},{"key":"2026100800433808000_ref35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.schres.2016.05.017","article-title":"How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression","volume":"176","author":"Stubbs","year":"2016","journal-title":"Schizophr Res"},{"key":"2026100800433808000_ref36","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s10935-024-00798-8","article-title":"Global prevalence of metabolic syndrome in schizophrenia patients: a systematic review and meta-analysis","volume":"45","author":"Salari","year":"2024","journal-title":"Journal of prevention (2022)"},{"key":"2026100800433808000_ref37","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/s2215-0366(16)30262-0","article-title":"The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis","volume":"3","author":"Perry","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"2026100800433808000_ref38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","article-title":"Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis","volume":"74","author":"Pillinger","year":"2017","journal-title":"JAMA psychiatry"}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/5\/sbag147\/70838701\/sbag147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article-pdf\/52\/5\/sbag147\/70838701\/sbag147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:44:20Z","timestamp":1791434660000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/article\/doi\/10.1093\/schbul\/sbag147\/8773377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,8,20]]}},"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbag147","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,20]]},"article-number":"sbag147"}}